FDA expands approved use of Stivarga to treat liver cancer

The U.S. Food and Drug Administration has expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been…



Source link

Would you like to get the test?